The Swedish Medicines Agency has previously rejected Moderna's application to test the vaccine. The vaccine is an mRNA vaccine, and Moderna is seeking full approval to offer the vaccine to adults aged 50 to 64.
Photo: Leon Neal/AP
Pharmaceutical company Moderna surged 8 percent in U.S. premarket trading after the announcement that the U.S. FDA will consider its flu shot.
Loading related articles...
Tags
Author
TBy TT News Agency. English edition by Sweden Herald, adapted for our readers
